Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 187 (TMEM187) is a multi-pass membrane protein encoded by a gene located on the X chromosome (two exons), designated as TMEM187 (HGNC:13705, UniProt:Q14656)[3][5][6]. TMEM187 is widely expressed in various tissues, including the nervous system, and has been found in several organ systems. It is not a receptor, enzyme, transporter, or recognized drug target. TMEM187 has been implicated in several genetic diseases, including leukodystrophy and Galloway-Mowat syndrome 2[3]. Notably, TMEM187 interacts with known autism-associated proteins (HCFC1, TMLHE, MeCP2, and GPHN), suggesting a possible role in neurodevelopmental processes[6]. There is currently no evidence that TMEM187 functions as a receptor or is targeted by any approved therapeutics, nor are there validated mechanisms of action, biomarker utilities, or notable drug safety concerns. Its molecular classification is a generic multi-pass transmembrane protein with no evidence for ion channel, transporter, or GPCR activity. Its exact physiological or pathophysiological function remains incompletely defined[3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 187 (TMEM187).